GeneDx Holdings Corp. (WGS)

SEC filing

GeneDx Holdings Corp.

WGS · CIK 1818331

4 · Mar 17, 2026 · Stueland Katherine sold 17.18K shares at $76.80/share ($1.3M); exercised options for 30.67K shares

Stueland Katherine sold 17.18K shares at $76.80/share ($1.3M); exercised options for 30.67K shares

xslF345X05/form4-03172026_100354.xml

xslF345X05/form4-03172026_100354.xmlSEC.gov

Graphics and non-inline formats (not embedded below).